ACIU
Price
$2.43
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
244.46M
10 days until earnings call
PHAT
Price
$9.63
Change
+$0.58 (+6.41%)
Updated
Jul 25 closing price
Capitalization
672.31M
11 days until earnings call
Interact to see
Advertisement

ACIU vs PHAT

Header iconACIU vs PHAT Comparison
Open Charts ACIU vs PHATBanner chart's image
AC Immune SA
Price$2.43
Change-$0.00 (-0.00%)
Volume$230.28K
Capitalization244.46M
Phathom Pharmaceuticals
Price$9.63
Change+$0.58 (+6.41%)
Volume$1.67M
Capitalization672.31M
ACIU vs PHAT Comparison Chart in %
Loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACIU vs. PHAT commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Buy and PHAT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ACIU: $2.43 vs. PHAT: $9.63)
Brand notoriety: ACIU and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 191% vs. PHAT: 61%
Market capitalization -- ACIU: $244.46M vs. PHAT: $672.31M
ACIU [@Biotechnology] is valued at $244.46M. PHAT’s [@Biotechnology] market capitalization is $672.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, ACIU is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 4 TA indicator(s) are bullish while PHAT’s TA Score has 3 bullish TA indicator(s).

  • ACIU’s TA Score: 4 bullish, 3 bearish.
  • PHAT’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ACIU is a better buy in the short-term than PHAT.

Price Growth

ACIU (@Biotechnology) experienced а +17.39% price change this week, while PHAT (@Biotechnology) price change was +21.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ACIU is expected to report earnings on Aug 06, 2025.

PHAT is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($672M) has a higher market cap than ACIU($244M). PHAT YTD gains are higher at: 18.596 vs. ACIU (-10.000). ACIU has higher annual earnings (EBITDA): -49.71M vs. PHAT (-272.12M). PHAT has more cash in the bank: 212M vs. ACIU (146M). ACIU has less debt than PHAT: ACIU (5.18M) vs PHAT (204M). PHAT has higher revenues than ACIU: PHAT (81.9M) vs ACIU (28.3M).
ACIUPHATACIU / PHAT
Capitalization244M672M36%
EBITDA-49.71M-272.12M18%
Gain YTD-10.00018.596-54%
P/E RatioN/AN/A-
Revenue28.3M81.9M35%
Total Cash146M212M69%
Total Debt5.18M204M3%
FUNDAMENTALS RATINGS
ACIU: Fundamental Ratings
ACIU
OUTLOOK RATING
1..100
44
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
87
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACIUPHAT
RSI
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OWLLX11.070.07
+0.64%
Channing Intrinsic Value Sm-Cp Instl
ETLNX15.650.10
+0.64%
Eventide Large Cap Focus N
NQVCX54.650.32
+0.59%
Nuveen Multi Cap Value C
GABIX49.810.16
+0.32%
Gabelli Asset I
HFQAX7.01-0.03
-0.43%
Janus Henderson Global Equity Income A

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with ARCT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
N/A
ARCT - ACIU
44%
Loosely correlated
-0.07%
RGNX - ACIU
44%
Loosely correlated
-1.86%
ABOS - ACIU
42%
Loosely correlated
N/A
CRBU - ACIU
41%
Loosely correlated
-3.80%
RXRX - ACIU
40%
Loosely correlated
+3.67%
More

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with RGNX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
+6.41%
RGNX - PHAT
36%
Loosely correlated
-1.86%
ACIU - PHAT
36%
Loosely correlated
N/A
URGN - PHAT
35%
Loosely correlated
+5.28%
PDSB - PHAT
34%
Loosely correlated
-2.48%
SYRE - PHAT
33%
Poorly correlated
+1.08%
More